Log in to search using one of your social media accounts:

 

Jacob ’s story: What it’s like to have a stroke as a kid
My name is Jacob and I’m 8 years old. Two years ago, I had a stroke. At first, I didn’t realize what that meant, and I didn’t understand why I couldn’t move the way I used to. With time, I’ve been able to get most of my function back, but my right arm has something called dystonia. That means the muscles cramp up and sometimes my arm moves on its own or gets stiff. I can’t control it, and that makes life hard sometimes. I come to Boston Children’s Hospital every few months to see Dr. Michael Rivkin at the Stroke and Cerebrovascular Center there. Nobody likes having to go to the do...
Source: Thrive, Children's Hospital Boston - September 26, 2017 Category: Pediatrics Authors: Jacob Downing Tags: Diseases & Conditions Our Patients’ Stories Dr. Michael Rivkin stroke Stroke and Cerebrovascular Center Source Type: news

Validation of fear of falling and balance confidence assessment scales in persons with dystonia - Boyce MJ, Lam L, Chang F, Mahant N, Fung VSC, Bradnam L.
BACKGROUND AND PURPOSE: Falls are problematic for people living with neurological disorders and a fear of falling can impact on actual falls. Fear of falling is commonly assessed using the Falls Self-Efficacy Scale International (FES-I) or the Activities-s... (Source: SafetyLit)
Source: SafetyLit - September 22, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Calvin ’s gift: Second opinion provides answers and hope
It’s not often that parents breathe a sigh of relief when their child is diagnosed with a chronic, potentially debilitating condition. But that sense of peace is just what Paula and Scott Hurd felt when they were told that their son, Calvin, had a rare movement disorder. “We were so happy to finally understand what was happening,” says Paula. Slipping away The search for answers had begun several years earlier, when Calvin started limping. At first, his family thought he had simply tripped over something and injured himself. But when he didn’t improve, they took him to the doctor. A series of appoi...
Source: Thrive, Children's Hospital Boston - September 13, 2017 Category: Pediatrics Authors: Jessica Cerretani Tags: Diseases & Conditions Our Patients’ Stories cerebral palsy Cerebral Palsy Program Dr. Benjamin Shore Dr. David Coulter dystonia Second opinion Source Type: news

Mayo Clinic picks up 11% stake in neuromod startup NeuroOne
The Mayo Clinic as acquired an 10.9% stake in epilepsy treatment neuromod startup NeuroOne’s parent firm, according an SEC filing from the company. NeuroOne is developing a “thin film” electrode technology, originally from the University of Wisconsin, designed to be implanted in the brain. The film can detect irregular brain activity, accurate to single neurons, to pinpoint the source of seizures and tremors, according to the filing, and has been used in testing at the Mayo Clinic. The technology combines detection alongside deep brain stimulation treatment and ablation capabilities to monitor and treat i...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neurological Neuromodulation/Neurostimulation Mayo Clinic neuroone Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 28, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Sirtex shares jump on restructuring plan, 15% headcount reduction Sirtex Medical saw shares jump today after revealing plans for a major restructuring as the company looks to cut its headcount and focus on its “profitable...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic wins CE Mark for SureTune3 deep-brain stimulation software
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its SureTune3 deep-brain stimulation software, which is designed to map lead locations and indicate the level of stimulation. The Fridley, Minn.-based Medtronic said its DBS devices are approved in the E.U. for treating Parkinson’s disease, dystonia, essential tremor, obsessive-compulsive disorder and epilepsy, claiming the portfolio as the only one to be full-body MR-conditional and able to operate during MRI scans. and is the only DBS complete portfolio that, under specific conditions, is full body MR conditional and can be ...
Source: Mass Device - June 28, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Regulatory/Compliance Medtronic Source Type: news

Impairments of balance, stepping reactions and gait in people with cervical dystonia - Barr C, Barnard R, Edwards L, Lennon S, Bradnam L.
BACKGROUND: Impaired balance is common in neurological disorders. Cervical dystonia is a neurological movement disorder affecting the neck. The effect of this aberrant head posture on physical function is unknown. OBJECTIVES: To compare balance, mo... (Source: SafetyLit)
Source: SafetyLit - April 25, 2017 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

23andMe is back: FDA allows marketing of genetic health risk tests
[Image courtesy of 23andMe]FDA this month allowed genetic testing company 23andMe to market genetic health risk tests for 10 diseases and conditions including Parkinson’s disease and late-onset Alzheimer’s disease. The de novo premarket review authorization, announced April 6, also included celiac disease, which results in the inability to digest gluten; alpha-1 antitrypsin deficiency, which raises the risk of lung and liver disease; early-onset primary dystonia, a movement disorder; factor XI deficiency, a blood clotting disorder; Gaucher disease type 1, a disorder involving organs and tissue; glucose-6-p...
Source: Mass Device - April 21, 2017 Category: Medical Equipment Authors: Chris Newmarker Tags: Business/Financial News Diagnostics Food & Drug Administration (FDA) Genomics Molecular Diagnostics News Well Regulatory/Compliance 23andme 23andMe Inc. MedTech Source Type: news

Study finds cause of rare neurological disorder
Researchers at the University of Liverpool in England have uncovered how a single gene mutation can cause the rare neurological disorder known as dystonia. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 10, 2017 Category: Consumer Health News Source Type: news

Cause of an inherited neurological disorder discovered
Researchers have identified the basis for how a single gene mutation can cause a rare neurological movement disorder known as dystonia. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 10, 2017 Category: Science Source Type: news

Cervical Spine Fusion for the Treatment of Refractory Idiopathic Cervical Dystonia Cervical Spine Fusion for the Treatment of Refractory Idiopathic Cervical Dystonia
Case study illustrating the multifaceted approach necessary to treat refractory cervical dystonia with concomitant rigid cervical kyphosis, in the face of neuromuscular pathology.HSS Grand Rounds Complex Cases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 15, 2017 Category: Consumer Health News Tags: Orthopaedics Clinical Case Source Type: news

Novel syndrome highlights the importance of rare disease research
(The Company of Biologists) Tuesday Feb. 28, 2017 is Rare Disease Day, and this year's slogan is 'With research, possibilities are limitless'. Disease Models& Mechanisms is marking the day by spotlighting a recent paper on a newly discovered deafness-dystonia syndrome documented in a family from Pakistan. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 27, 2017 Category: Biology Source Type: news

Novel syndrome highlights the importance of rare disease research
(The Company of Biologists) Tuesday, Feb. 28, 2017, is Rare Disease Day, and this year's slogan is 'With research, possibilities are limitless.' Disease Models& Mechanisms is marking the day by spotlighting a recent paper on a newly discovered deafness-dystonia syndrome documented in a family from Pakistan. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 27, 2017 Category: Global & Universal Source Type: news

Gene Discovery Helps Children with Dystonia and Movement Disorder Walk Again
Researchers discover new genetic cause for dystonia, a movement disorder, enabling treatment with Deep Brain Stimulation which has been so successful that children have been able to walk again (Source: Disabled World)
Source: Disabled World - December 20, 2016 Category: Disability Tags: Medical Research Source Type: news

Children with dystonia can walk again with the help of a brain implant
The research from University College London, Great Ormond Street Hospital, and Cambridge University found that the effects were strongest in the youngest patients. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2016 Category: Consumer Health News Source Type: news

Scientists develop new drug screening tool for dystonia
Researchers have identified a common mechanism underlying separate forms of dystonia, a family of brain disorders that cause involuntary, debilitating and often painful movements, including twists and turns of different parts of the body. The research has led to the development of a new cell-based test that is being deployed on a large scale to identify new drug candidates to treat dystonia. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 8, 2016 Category: Science Source Type: news

Scientists develop new drug screening tool for dystonia
(Duke University) Duke University researchers have identified a common mechanism underlying separate forms of dystonia, a family of brain disorders that cause involuntary, debilitating and often painful movements, including twists and turns of different parts of the body. The research has led to the development of a new cell-based test that is being deployed on a large scale to identify new drug candidates to treat dystonia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 8, 2016 Category: Global & Universal Source Type: news

Impaired heart rate variability in cervical dystonia is associated to depression - Hentschel F, Dressler D, Abele M, Paus S.
Causes of cardiovascular autonomic dysfunction in cervical dystonia (CD) are poorly understood. Studies examining effects of botulinum neurotoxin (BoNT) therapy on heart rate variability (HRV) yielded contradictory results. There is compelling evidence tha... (Source: SafetyLit)
Source: SafetyLit - November 11, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Deep brain stimulation surgery while asleep brings relief from dystonia
Treatment TermsParkinson's and other movement disorders CategoriesTreatments/research advancementsWomen's healthMen's health Additional SEO Keywords deep brain stimulation, dbs surgery, dbs, brain stimulation, dystonia, SEO Meta Description Thomas Galvin suffered dystonia symptoms for decades —until technology at Duke allowed him to have deep brain stimulation surgery while asleep Overview Raleigh resident Thomas Galvin suffered involuntary muscle contractions for decades —until technology at Duke allowed him to have surgery while asleep to quell the repetitive movements. Hero Imagetom_ga...
Source: dukehealth.org: Duke Health News - August 1, 2016 Category: Consumer Health News Authors: mf205 at duke.edu Source Type: news

Botox and Dystonia
LAS VEGAS, Nev. (Ivanhoe Newswire) -- Long before it wiped out worry lines and age wrinkles, Botox was originally created to stop muscle spasms in the eye. Besides its fountain-of-youth qualities, it’s being used to relieve exhausting and sometimes debilitating effects of a neurological disorder called dystonia. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - July 5, 2016 Category: Consumer Health News Source Type: news

St. Jude wins CE Mark, launches SyncAV CRT algorithm
St. Jude Medical (NYSE:STJ) said today it won CE Mark approval in the European Union and launched its SyncAV CR software algorithm designed to optimize the company’s MultiPoint pacing technology. The newly released software algorithm is designed to address and treat heart failure patients who are not responsive to other pacing options, and can automatically adjust pacing based on real-time changes in cardiac condition. “Although we have made substantial improvements in how we treat heart failure patients, there are still certain patients who are not getting the outcomes with traditional CRT that we would l...
Source: Mass Device - June 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiac Assist Devices Cardiac Implants Cardiovascular Regulatory/Compliance Software / IT St. Jude Medical Source Type: news

St. Jude launches Infinity deep brain stim system in the EU
St. Jude Medical (NYSE:STJ) today announced the European launch of its Infinity deep brain stimulation system and direction DBS lead, designed to support treatments for movement disorders. The Infinity DBS system won CE Mark approval in the European Union last September. “The Infinity system is the 1st DBS system I’ve encountered that adjusts to the patient’s individual needs, rather than forcing the patient to adjust to the system. Offering my patients a DBS system with exceptional ease of use and smooth manageability is an exciting step in the treatment of debilitating movement disorders,...
Source: Mass Device - June 16, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological St. Jude Medical Source Type: news

Behavioural Interventions for Adult-Onset Primary DystoniaBehavioural Interventions for Adult-Onset Primary Dystonia
Have any behavioral interventions proved beneficial in improving quality of life for people with primary dystonia? BMC Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2016 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Updated guidance on botulinum toxin formulations for four indications
The American Academy of Neurology has issued an update to its 2008 guidelines on the use of botulinum toxin for the treatment of spasticity, cervical dystonia, blepharospasm and migraine headache. (Source: MedWire News)
Source: MedWire News - April 26, 2016 Category: Consumer Health News Tags: Neurology Source Type: news

AAN updates botulinum toxin guidelines for most established uses
VANCOUVER – A new American Academy of Neurology practice guideline on the efficacy and safety evidence for botulinum toxin treatment of blepharospasm, cervical dystonia, spasticity, and headache has... (Source: Clinical Neurology News)
Source: Clinical Neurology News - April 19, 2016 Category: Neurology Source Type: news

AAN updates botulinum toxin guidelines for most established uses
VANCOUVER – A new American Academy of Neurology practice guideline on the efficacy and safety evidence for botulinum toxin treatment of blepharospasm, cervical dystonia, spasticity, and headache has... (Source: Family Practice News)
Source: Family Practice News - April 19, 2016 Category: Primary Care Source Type: news

New AAN Guideline on Use of Botulinum NeurotoxinsNew AAN Guideline on Use of Botulinum Neurotoxins
The American Academy of Neurology has released new recommendations on the use of botulinum neurotoxin products in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 18, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Zonisamide relieves myoclonus dystonia motor symptoms
A randomised crossover trial shows that zonisamide significantly improves motor symptoms and related disability in adults with myoclonus dystonia. (Source: MedWire News)
Source: MedWire News - April 12, 2016 Category: Consumer Health News Tags: Movement disorders Source Type: news

This Treatment Could Alleviate Chronic Pain Without Opioid Medications
Researchers at the University of Texas at Arlington have been working on a new way to treat chronic pain -- and it just might help curb the rampant abuse of opioid medicines prescribed for pain management. Using a wireless device, the researchers demonstrated in lab rats how electrically stimulating an area hidden deep in the brain could relieve long-term pain. The method could offer a new way to alleviate chronic pain without the negative side effects of opioid medications, said Dr. Yuan Bo Peng, a psychology professor at the university and a corresponding author of the new research. Each day, more tha...
Source: Healthy Living - The Huffington Post - April 5, 2016 Category: Consumer Health News Source Type: news

This Treatment Could Alleviate Chronic Pain Without Opioid Medications
Researchers at the University of Texas at Arlington have been working on a new way to treat chronic pain -- and it just might help curb the rampant abuse of opioid medicines prescribed for pain management. Using a wireless device, the researchers demonstrated in lab rats how electrically stimulating an area hidden deep in the brain could relieve long-term pain. The method could offer a new way to alleviate chronic pain without the negative side effects of opioid medications, said Dr. Yuan Bo Peng, a psychology professor at the university and a corresponding author of the new research. Each day, more tha...
Source: Science - The Huffington Post - April 5, 2016 Category: Science Source Type: news

FDA Issues Draft Guidance For IDEs For Neurological Devices
The U.S. Food and Drug Administration (FDA) released a draft guidance for sponsors who wish to submit an investigational device exemption (IDE) to conduct trials for devices intended to slow, stop, or reverse the effects of neurological diseases, including Alzheimer's disease, Parkinson's disease, or primary dystonia. (Source: Medical Design Online News)
Source: Medical Design Online News - March 8, 2016 Category: Medical Equipment Source Type: news

Engineered Surface Tubing
Zeus offers Engineered Surface Tubing designed specifically for the neurostimulation treatment of Dystonia; a neurological movement disorder primarily related to Parkinson’s disease. This surface tubing features highly lubricated surfaces, making treatment delivery easier for surgeons and safer for patients. (Source: Medical Design Online Products)
Source: Medical Design Online Products - March 2, 2016 Category: Medical Equipment Source Type: news

International Perspectives: Clinical Kernicterus in Preterm Infants in Japan
In recent years, clinical kernicterus has been diagnosed in preterm infants on the basis of motor (kinetic) disorders such as choreoathetosis and dystonia, impairment in auditory neuropathy-type hearing, and abnormal pallidal signals on head magnetic resonance imaging. In Japan, it is currently estimated that at least 8 to 9 cases of kernicterus (approximately 2 per 1,000 cases) occur annually in preterm infants of less than 30 weeks’ gestation. Therefore, there is an urgent need to revise our jaundice management approach in preterm infants. Two major characteristics of Japanese preterm infants who develop clinical k...
Source: NeoReviews recent issues - March 1, 2016 Category: Pediatrics Authors: Morioka, I., Nakamura, H., Iwatani, S., Wong, R. J., Iijima, K. Tags: Pediatric Drug Labeling Update Articles Source Type: news

Researchers hope brain's plasticity can be used to treat disorders
Exactly what triggers dystonia — an involuntary muscle contraction of the hand, fingers, neck or mouth, which is sometimes very painful — is unclear. But some researchers think the underlying problem that causes it may also be the key to treating it, and other brain-linked disorders like Parkinson's. (Source: CBC | Health)
Source: CBC | Health - February 25, 2016 Category: Consumer Health News Tags: News/Health Source Type: news

Intensive instrument playing can lead to movement disorders
(Deutsches Aerzteblatt International) In total, one in 6,600 persons will develop focal dystonia, whereas an estimated one in 100 musicians will succumb. This is the finding of an original article by Verena Eveline Rozanski and coauthors in the current issue of Deutsches Ärzteblatt International. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2016 Category: Global & Universal Source Type: news

Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
An overdose of Guaifenesin DM may cause hyper excitability, rapid eye movements, changes in muscle reflexes, ataxia, dystonia, hallucinations, stupor, and coma. (Source: FDA MedWatch)
Source: FDA MedWatch - January 13, 2016 Category: American Health Source Type: news

VIDEO: 'Disability doesn't mean anything'
A model with cerebral palsy and dystonia is having deep-brain surgery which she hopes will help with mobility and is on a mission to fight misconceptions about disability. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 13, 2016 Category: Consumer Health News Source Type: news

Recall Issued For Children’s Cold Medicine
BOSTON (CBS) — A recall for a children’s cold medicine sold by retailers like CVS and Stop and Shop has been issued. In a release posted on the company’s website, Perrigo Company said they had issued a recall for two batches of their children’s guaifenesin grape liquid and three batches of their children’s guaifenesin DM cherry liquid. Both products are sold in 4 oz. bottles with a dosage cup included in the package. The recall was issued because the markings on some of the dosage cups are inaccurate–which could lead to overdoses. “There have been no reports of adver...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 12, 2016 Category: Consumer Health News Authors: Jon Palmer Tags: Health Local News Syndicated Local drug recall Perrigo Source Type: news

Get the picture: The UCLA Brain Mapping Center
A woman with major depression lies as motionless as she can, her head inside the doughnut hole of an MRI scanner that clangs, beeps, chirps and buzzes as it captures images of neural activity. She’s wearing headphones so she can listen to Pandora. However, brain mappers can see on their computer screens what’s going on in her head. At the UCLA Ahmanson-Lovelace Brain Mapping Center (ALBMC), they are measuring her brain’s structure, shape, chemistry and function before treating her with electroconvulsive therapy. A few days after the treatment, they’ll map her again to compare the before and after. ...
Source: UCLA Newsroom: Health Sciences - January 4, 2016 Category: Universities & Medical Training Source Type: news

Master one of the most missed USMLE questions
With finals behind you, take a few minutes to sharpen your skills for the United States Medical Licensing Examination® (USMLE®) with this exclusive scoop on one of the most challenging USMLE test prep questions and expert strategies to help you ace it. Find out what this month’s toughest question is and receive an expert video explanation of the answer from Kaplan Medical. Welcome to the fourth post in AMA Wire’s® series, “Tutor talk: Tips from Kaplan Medical on the most missed USMLE test prep questions from Kaplan’s Step 1 Qbank.” Each month, we’re revealing one of the top...
Source: AMA Wire - December 28, 2015 Category: Journals (General) Authors: Lyndra Vassar Source Type: news

Dystonia not dystopia: effects of the legal high, 'Clockwork Orange' - Mackey HE, Hawksley O.
A 27-year-old man presented to hospital after smoking a legal high named 'Clockwork Orange'. He suffered dystonia, acute kidney injury, rhabdomyolysis, lactic acidosis and a troponin rise. He was treated with procyclidine and intravenous fluids. L... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - December 19, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

How Tim Froio became a bionic man
Tim (far right) five years ago with his father Jon, mother Cheralyn and brothers Jonathan and Brandon Timothy Froio has spent his life plagued by sudden, unwanted jerky movements. “As a baby, he’d drift off to sleep in my arms and then jump, as if he felt like he was falling,” says his mother, Cheralyn. “He would jump so much that his body would stiffen.” At age 2, putting together Legos, Tim struggled with violent tic-like movements in his upper torso, arms, legs, neck and head. “He’d jerk and the Legos would come apart and go all over,” says Cheralyn. The same thing happene...
Source: Thrive, Children's Hospital Boston - November 3, 2015 Category: Pediatrics Authors: Nancy Fliesler Tags: All posts Diseases & conditions autism Dr. Jeff Waugh Dr. Scellig Stone movement disorders myoclonus neurology Source Type: news

Revance begins Phase II trial of botulinum toxin type A for injection to treat cervical dystonia
US-based biopharmaceutical firm Revance Therapeutics has started dosing in a Phase II dose-escalating clinical trial of an investigational drug product candidate, RT002, to treat cervical dystonia, a neurological muscle movement disorder. (Source: Drug Development Technology)
Source: Drug Development Technology - September 29, 2015 Category: Pharmaceuticals Source Type: news

St. Jude Medical wins CE Mark for Infinity DBS device
St. Jude Medical (NYSE:STJ) said today that it won CE Mark approval in the European Union for its Infinity deep-brain stimulation device and directional lead for treating movement disorders. Little Canada, Minn.-based St. Jude said the Infinity system is designed so that Apple (NSDQ:AAPL) mobile devices can be used as wireless controllers, via a Bluetooth connection. It’s the only upgradable DBS system for movement disorders including Parkinson’s disease, tremor and dystonia. The directional leads are designed to allow doctors to “steer” current to different parts of the brain, tailoring t...
Source: Mass Device - September 22, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Regulatory/Compliance CE Mark Deep-brain stimulation St. Jude Medical Source Type: news

DRC: MSF Treats Over 500 People After Drug Poisoning
Field newsDRC: MSF Treats Over 500 People After Drug Poisoning September 18, 2015 In early January 2015, MSF was alerted by the local health authorities of a possible meningitis epidemic in the Ituri region of Democratic Republic of Congo (DRC). The patients were presenting with mysterious symptoms, including involuntary twitching and motor impairment (dystonia), abnormal posture, and facial assymetry. (Source: MSF News)
Source: MSF News - September 18, 2015 Category: Global & Universal Authors: Elias Primoff Source Type: news

Boston Scientific Gets CE Mark For Vercise PC Deep Brain Stimulation System
Boston Scientific announced recently the CE Mark designation for its Vercise Primary Cell (PC) Deep Brain Stimulation (DBS) System for patients suffering from Parkinson's disease (PD), primary and secondary dystonia, and essential tremor. Vercise PC is a non-rechargeable system that complements the company's rechargeable device in its new DBS portfolio. (Source: Medical Design Online News)
Source: Medical Design Online News - September 14, 2015 Category: Medical Equipment Source Type: news

Boston Scientific wins CE Mark for Vercise DBS component
Boston Scientific (NYSE:BSX) today said it won CE Mark approval in the European Union for a component of its Vercise deep brain stimulation device that allows physicians to “steer” electric currents to different parts of the brain. Natick, Mass.-based Boston Scientific 1st won CE Mark approval for Vercise in 2012. The most recent mark covers its Vercise primary cell device, which in conjunction with a directional lead, is designed to “provide precise neural targeting” in treating Parkinson’s disease, dystonia and essential tremor, the company said. “This new system ex...
Source: Mass Device - September 10, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Regulatory/Compliance Source Type: news

Yes You Can: How running with Team Hoyt changed this father’s life
Elijah Gauthier, 3, and Rick Hoyt, 53, have a lot in common. Both are first-born sons. Both have smiles that light up a room. Both love running with their fathers. And both have faced incredible challenges. Elijah and Rick were diagnosed with cerebral palsy early in life. They can’t walk. They can’t speak. When Rick was born, his parents were told, “He’s a vegetable. Put him in an institution.” They refused. Since then, Rick and his father Dick Hoyt have inspired parents and families around the world. The father-son team has logged more than 1,100 races, with Dick pushing Rick in a specially d...
Source: Thrive, Children's Hospital Boston - June 18, 2015 Category: Pediatrics Authors: Lisa Fratt Tags: Our patients’ stories parenting cerebral palsy orthopedics Source Type: news

Ataxia with Parkinsonism and dystonia after intentional inhalation of liquefied petroleum gas - Godani M, Canavese F, Migliorini S, Sette MD.
The practice of inhaling liquefied petroleum gas (LPG) to commit suicide is uncommon and almost exclusively a prerogative of the prison population. Numerous cases of sudden deaths caused by intentional propane and/or butane inhalation have been described, ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 10, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Relief of dystonia symptoms is sustained in pediatric patients undergoing deep brain stimulation
Children and adolescents who received deep brain stimulation for generalized dystonia maintained significant symptom relief for up to eight years, according to a study. The results reinforce the observation that patients with a shorter duration of symptoms, and a younger age at implantation, experience better outcomes, researchers say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2015 Category: Science Source Type: news